Technology | 2016.02.02
OptiNose® Announces Pipeline Project to Evaluate Nose-to-Brain Application of Bi-Directional™ Breath Powered® Technology Selected for Norwegian Government Funding
YARDLEY, Pa.--(BUSINESS WIRE)--OptiNose Inc., a privately-held Delaware specialty biopharmaceutical company, today announced that its Norwegian affiliate (OptiNose AS) was selected to receive up to NOK 15.9 million (USD $1.8 million) by the Research Council of Norway to study its unique nasal drug delivery technology in the treatment of Narcolepsy. The OptiNose proposal was one of 50 company projects selected from among 181 applications submitted to the Research Council’s program for User-Drive
For more information, please visit
http://www.businesswire.com/news/home/20[...]uate-Nose-to-Brain-Application
Instagram is adding automatic in-app text translation - The Verge views: 1528
Here’s a ‘Brand-New’ Massive Multilingual Dataset for Machine Translation views: 1522